3653 results for «358»
3653 results
Optimised patient selection for carotid artery stenting
22 May 2025 – From EuroPCR 2025
Optimize patient selection for carotid artery stenting with this session that highlights personalized approaches to ischaemic stroke treatment. Review bioactive stents versus endovascular therapy, feasibility and outcomes in near-occlusion cases, and long-term retrospective analyses supporting carotid stenting as a strategic ally in embolic stroke management.
LAA closure in challenging scenarios
22 May 2025 – From EuroPCR 2025
This session addresses the complexities of left atrial appendage (LAA) closure in challenging anatomical and clinical scenarios. Learn from compelling cases including management of incomplete surgical LAA ligation, closure of large and complex peridevice leaks, and navigating difficult anatomy in elderly patients. Emphasizing innovative techniques and...
Contemporary outcomes of PCI patients
22 May 2025 – From EuroPCR 2025
Examine contemporary outcomes in PCI patients through a collection of studies addressing angiographic complication incidences, safety of same-day discharge post-complex PCI, age-related outcome impacts in TAVI patients, and comparative long-term antiplatelet strategies. The session also explores timing effects in routine versus off-hours PCI.
Anatomy, physiology and clinical judgment: insights from contemporary strategies to guide PCI
22 May 2025 – From EuroPCR 2025
Discover contemporary strategies integrating anatomy, physiology, and clinical judgment to guide percutaneous coronary intervention (PCI). This session explores the impact of stress cardiovascular magnetic resonance in primary prevention, viability-guided PCI, and physiology-based decision-making including quantitative flow ratio (QFR). Learn about identifying patients at risk for major...
Updates on percutaneous treatment of pulmonary embolism
22 May 2025 – From EuroPCR 2025
Stay abreast of the latest advances in percutaneous treatment of pulmonary embolism. This session covers clinical outcomes with novel vacuum thrombectomy devices, mechanical thrombectomy registries, catheter-directed therapies in intermediate-high risk PE, and profiles of subacute PE interventions to inform optimal treatment strategies.
DCB in STEMI : why, when and how ?
22 May 2025 – From EuroPCR 2025
Explore the evolving role of drug-coated balloons (DCB) in the management of STEMI patients. This session covers practical approaches including primary PCI with DEB, unconventional solutions in urgent scenarios, and personalized treatment strategies especially in very young patients. Learn how DCB technology intersects with complex lesion...
Percutaneous aortic interventions: mastering the complexity
22 May 2025 – From EuroPCR 2025
Master complex percutaneous aortic interventions in this detailed session. Topics include managing life-threatening complications, percutaneous repair of ascending aortic graft pseudoaneurysms, aortic stenting for total occlusions, and troubleshooting endovascular aortic repair failures, providing a comprehensive overview of challenging aortic cases.
Acute complications during distal left main PCI - Part 1
22 May 2025 – From EuroPCR 2025
Navigate the challenges of acute complications during distal left main PCI with expert guidance. This session discusses troubleshooting techniques for stuck IVUS catheters, stepwise ostial LAD stenting, OCT applications when crush and kiss techniques fail, management of lost stents in heavily calcified bifurcations, and responses to...
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk
07 Nov 2021
Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...
Author
Author
World Heart Day 2023: Reducing the burden of cardiovascular disease globally: beyond stents and balloons!
29 Sep 2023
Global burden of Cardiovascular Disease
Cardiovascular disease (CVD) remains the lead cause of mortality for men and women globally. Our world population in 2023 is 8 billion! Of these, around 620 million people are living with heart and circulatory diseases across the world. Each year around 60...
Author
The Lancet Commission to reduce global burden of cardiovascular disease in women by 2030
29 Aug 2021
Vijay Kunadian summarizes the key points of the LBT session of the ESC congress 2021 held on Sunday, 29 August focusing on the Lancet Commission to reduce the global burden of heart disease in women by 2030.
Author
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
08 Jan 2025
In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.
Author
